About Us
We’ve built an integrated commercial services platform. Greater success for clients. Better outcomes for patients.
EVERSANA is a leading independent provider of global services to the life sciences industry.
The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 670 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world
Discover Our Difference
Leaders
We’re driven by a diverse team of experienced leaders who understand the challenges facing today’s industry.
Insights
Stay on top of the latest industry trends and insights through our white papers, webinars and more.
We’re making headlines as we grow our team and expand our capabilities. See our most recent news here!
-
Media Contacts:
Matt Braun [email protected] -
June 9, 2026
EVERSANA Strengthens Commitment to Driving Market Access Growth with Addition of Industry Expert Jen Norton
-
May 6, 2026
EVERSANA Appoints Agency and Commercialization Veteran Mike Guarino to Lead Global Agency EVERSANA INTOUCH
-
April 29, 2026
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer
-
April 27, 2026
Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.